With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...

Colgate-Palmolive (CL) has slid about 16% over the past year, and that pullback is getting income focused investors to revisit this steady consumer staples name as a potential value and dividend play.

Colgate-Palmolive (CL) shares have been under pressure for over a year as slowing global category growth has weighed on the stock and ended the company’s run of organic sales at or above their ...

Introducing the Industry's First Oral Care "Blind Box" Series: Miniature City Landmarks Designed to Inspire Greater ...

Procter & Gamble (NYSE: PG) stock has recently caught attention after Jim Cramer made a positive case for the stock. Both PG and its rival Colgate-Palmolive (CL) are down approximately 12% ...

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and ...

BofA raised the firm’s price target on Colgate-Palmolive (CL) to $90 from $88 and keeps a Buy rating on the shares. Entering 2026, the largest unresolved question for staples remains consumption ...

Investing.com - Argus downgraded Colgate-Palmolive Company (NYSE:CL) from Buy to Hold on Thursday, citing margin pressures and minimal growth outlook. The consumer products giant, currently trading at ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

FORT LAUDERDALE, Fla., Jan. 6, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Philip Berry is honored as a Pinnacle Professional Member Inner Circle of Excellence for his contributions ...